Industry Given CAT Relief Due to Coronavirus [UPDATE]

The SEC has released a no-action letter, delaying deadlines for the Consolidated Audit Trail until at least mid-May.

FRTB-capital-charges-face-delay

April was to be a big month for the rollout of the long-awaited Consolidated Audit Trail, otherwise known as the CAT. But in the face of a global pandemic, the CAT will have to wait a bit longer to come to life.

On March 17, the US Securities and Exchange Commission (SEC) released a no-action letter that will last through mid-May.

“We understand that COVID-19’s impact on market participants, including necessitating [self-regulatory organizations] and industry members to implement their

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Europe is counting its vendors—and souring on US tech

Under DORA, every financial company with business in the EU must report use of their critical vendors. Deadlines vary, but the message doesn’t: The EU is taking stock of technology dependencies, especially upon US providers.

The European T+1 effect on Asia

T+1 is coming in Europe, and Asian firms should assess impacts and begin preparations now, says the DTCC’s Val Wotton.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here